Table 9.

Significant findings after multiple regression analyses of covariates with mortality.

	Overall patients(n = 93). P value.	Asthma and allergy patients (n = 21). P value.	Other patients(n = 72). P value.
Age	0.001	n.s.	0.013
Comorbidity excluding asthma or allergy
Antecedents of cerebrovascular disorders	0.008	–	0.026
Drugs used in cardiovascular diseases
Oral anticoagulants	0.007	n.s.	n.s.
Platelet Antiaggregants	0.034	n.s.	n.s.
Pain relief medications
Non-steroidal anti-inflammatory drugs	0.047	n.s.	0.052
Psychiatric medications
Selective serotonin reuptake inhibitors	0.004	n.s.	0.022
Drug used in neurological diseases
Antiepileptic drugs	0.028	n.s.	0.022
Other drugs
Proton pump inhibitors	0.011	n.s.	n.s.
Laboratory and clinical findings
Oxygen saturation	0.007	n.s.	0.017
Lymphocytes	0.034	n.s.	n.s.
Eosinophils	0.010	n.s.	0.021
Interleukin-6	0.001	n.s.	0.001
Drug therapy after admission
Lopinavir plus ritonavir	0.011	n.s.	0.005